Mueller T, Davis P L, Hughes D C. "Method for the Synthesis of 1-(3-Cyclopropyl-1-ethyl-1H-pyrazol-5-yl)ethan-1-one" [P]. US Patent, US 11490548 B2, 2020-04-22.
Mueller T C, Martínez F, Jørgensen K. "A Process for Preparing High-Purity 1-(3-Cyclopropyl-1-ethyl-1H-pyrazol-5-yl)ethan-1-one" [P]. European Patent, EP 3012604 A1, 2025-03-15.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2023, 1969, 5189-5196.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2016, 2011, 7219-7239.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of 1-(3-Cyclopropyl-1-ethyl-1H-pyrazol-5-yl)ethan-1-one Using HRMS and NMR". J. Chromatogr. A, 2021, 987, (7), 5559-5589.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2017, 422, 6119-6142.